Literature DB >> 5296394

The use of catalytic models as tools for elucidating the clinical and epidemiological features of trachoma.

F A Assaad, F Maxwell-Lyons.   

Abstract

A change in the clinical pattern of trachoma from a grave to a milder form has been noted in several endemic areas in recent years and has been attributed to improvements in bio-physical conditions, as well as to specific control measures. The disease, thus modified, frequently presents difficulty in diagnosis under field conditions, and equivocal cases, which are sometimes encountered in relatively large numbers, pose a problem in the assessment of over-all incidence, prevalence and relative gravity of trachoma in the area. The problem assumes particular importance in field studies, such as therapeutic and vaccination trials.In an attempt to determine by epidemiological methods the true nature of these clinically equivocal cases, the data collected during a survey of the prevalence of trachoma in Taiwan have been subjected to an intensive study with the aid of catalytic models. The evidence is that most, if not all, of these cases are trachomatous.

Entities:  

Mesh:

Year:  1966        PMID: 5296394      PMCID: PMC2475983     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  3 in total

1.  OCULAR SYNDROMES OF TRIC VIRUS INFECTION AND THEIR POSSIBLE GENITAL SIGNIFICANCE.

Authors:  B R JONES
Journal:  Br J Vener Dis       Date:  1964-03

2.  EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT.

Authors:  Y Mitsui; K Konishi; A Nishimura; M Kajima; O Tamura; K Endo
Journal:  Br J Ophthalmol       Date:  1962-11       Impact factor: 4.638

3.  Etiology of trachoma.

Authors:  Y MITSUI
Journal:  Am J Ophthalmol       Date:  1949-09       Impact factor: 5.258

  3 in total
  11 in total

1.  [Simple exponential model: catalytic function in tuberculin epidemiometry].

Authors:  A Lafaye
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

2.  Report of 4 years' follow-up of a trachoma clinical trial in Taiwan.

Authors:  F A Assaad; F Maxwell-Lyons; T Sundaresan
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  Use of local variations in trachoma endemicity in Taiwan to elucidate some of the clinical and epidemiological aspects of the disease.

Authors:  F A Assaad; F Maxwell-Lyons; T Sundaresan
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Systematic oserver variation in trachoma studies.

Authors:  F A Assaad; F Maxwell-Lyons
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

Review 5.  Diagnosis and assessment of trachoma.

Authors:  Anthony W Solomon; Rosanna W Peeling; Allen Foster; David C W Mabey
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Clinical evaluation of the Taiwan trachoma control programme.

Authors:  F A Assaad; T K Sundaresan; C Y Yang; L J Yeh
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  The household pattern of trachoma in Taiwan.

Authors:  F A Assaad; T Sundaresan; F Maxwell-Lyons
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  The ecology of trachoma: an epidemiological study in southern Mexico.

Authors:  H R Taylor; F M Velasco; A Sommer
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  The use of simple epidemiological models in the evaluation of disease control programmes: a case study of trachoma.

Authors:  T K Sundaresan; F A Assaad
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

10.  Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?

Authors:  Tamsyn Derrick; Martin J Holland; Eunice Cassama; Rod Markham-David; Meno Nabicassa; Michael Marks; Robin L Bailey; Anna R Last
Journal:  Parasit Vectors       Date:  2016-01-27       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.